Drug survival of secukinumab in real-world plaque psoriasis patients: A 52-week, multicenter, retrospective study

J Am Acad Dermatol. 2018 May;78(5):1019-1020. doi: 10.1016/j.jaad.2017.11.036. Epub 2017 Nov 24.
No abstract available

Publication types

  • Multicenter Study

MeSH terms

  • Adult
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Canada
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Female
  • Follow-Up Studies
  • Global Health
  • Humans
  • Male
  • Middle Aged
  • Patient Safety
  • Psoriasis / diagnosis*
  • Psoriasis / drug therapy*
  • Retrospective Studies
  • Severity of Illness Index
  • Time Factors
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • secukinumab